Oncocyte Corp Annual Share-based Payment Arrangement, Expense in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Oncocyte Corp quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2014 to 2023.
  • Oncocyte Corp Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $450K, a 26% decline year-over-year.
  • Oncocyte Corp Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.74M, a 64.5% decline year-over-year.
  • Oncocyte Corp annual Share-based Payment Arrangement, Expense for 2023 was $2.76M, a 72.5% decline from 2022.
  • Oncocyte Corp annual Share-based Payment Arrangement, Expense for 2022 was $10M, a 46.8% increase from 2021.
  • Oncocyte Corp annual Share-based Payment Arrangement, Expense for 2021 was $6.84M, a 35% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $2.76M -$7.28M -72.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $10M +$3.2M +46.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $6.84M +$1.78M +35% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-12
2020 $5.07M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2017 $1.63M +$708K +76.8% Jan 1, 2017 Dec 31, 2017 10-K 2018-04-02
2016 $922K -$893K -49.2% Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2015 $1.82M +$1.5M +471% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-02
2014 $318K Jan 1, 2014 Dec 31, 2014 10-K 2017-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.